These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 28567714)
1. Epidemiology of hip fracture and the development of FRAX in Ukraine. Povoroznyuk VV; Grygorieva NV; Kanis JA; Ev M; Johansson H; Harvey NC; Korzh MO; Strafun SS; Vaida VM; Klymovytsky FV; Vlasenko RO; Forosenko VS Arch Osteoporos; 2017 Dec; 12(1):53. PubMed ID: 28567714 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model. Zakroyeva A; Lesnyak O; Cazac V; Groppa L; Russu E; Chislari L; Rotaru L; Johansson H; Harvey NC; McCloskey E; Lorentzon M; Kanis JA Arch Osteoporos; 2020 Jan; 15(1):13. PubMed ID: 31993755 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models. Ramanau H; Chernyanin I; Rudenka E; Lesnyak O; Zakroyeva A; Bilezikian JP; Johansson H; Harvey NC; McCloskey EV; Kanis JA Arch Osteoporos; 2018 Apr; 13(1):42. PubMed ID: 29666948 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model. Issayeva S; Lesnyak O; Zakroyeva A; Issayeva B; Dilmanova D; Johansson H; Liu E; Lorentzon M; Harvey NC; McCloskey E; Kanis JA Arch Osteoporos; 2020 Feb; 15(1):30. PubMed ID: 32108270 [TBL] [Abstract][Full Text] [Related]
5. The effects of a FRAX revision for the USA. Kanis JA; Johansson H; Oden A; Dawson-Hughes B; Melton LJ; McCloskey EV Osteoporos Int; 2010 Jan; 21(1):35-40. PubMed ID: 19705047 [TBL] [Abstract][Full Text] [Related]
6. Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study. Ettinger B; Ensrud KE; Blackwell T; Curtis JR; Lapidus JA; Orwoll ES; Osteoporos Int; 2013 Apr; 24(4):1185-93. PubMed ID: 23179575 [TBL] [Abstract][Full Text] [Related]
7. Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures. Lalmohamed A; Welsing PM; Lems WF; Jacobs JW; Kanis JA; Johansson H; De Boer A; De Vries F Osteoporos Int; 2012 Mar; 23(3):861-9. PubMed ID: 22120910 [TBL] [Abstract][Full Text] [Related]
8. Incidence of hip fracture in Brazil and the development of a FRAX model. Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model. Kirilova E; Johansson H; Kirilov N; Vladeva S; Petranova T; Kolarov Z; Liu E; Lorentzon M; Vandenput L; Harvey NC; McCloskey E; Kanis JA Arch Osteoporos; 2020 Feb; 15(1):28. PubMed ID: 32108268 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate. Lesnyak O; Sahakyan S; Zakroyeva A; Bilezikian JP; Hutchings N; Babalyan V; Galstyan R; Lebedev A; Johansson H; Harvey NC; McCloskey E; Kanis JA Arch Osteoporos; 2017 Nov; 12(1):98. PubMed ID: 29116417 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology of hip fracture in Qatar and development of a country specific FRAX model. Abdulla N; Alsaed OS; Lutf A; Alam F; Abdulmomen I; Al Emadi S; Harvey NC; Liu E; Vandenput L; Lorentzon M; McCloskey E; Kanis JA; Johansson H Arch Osteoporos; 2022 Mar; 17(1):49. PubMed ID: 35303174 [TBL] [Abstract][Full Text] [Related]
12. FRAX® probabilities and risk of major osteoporotic fracture in France. Couris CM; Chapurlat RD; Kanis JA; Johansson H; Burlet N; Delmas PD; Schott AM Osteoporos Int; 2012 Sep; 23(9):2321-7. PubMed ID: 22179418 [TBL] [Abstract][Full Text] [Related]
13. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509 [TBL] [Abstract][Full Text] [Related]
14. Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model. Lopez Gavilanez E; Johansson H; McCloskey E; Harvey NC; Segale Bajana A; Marriott Blum D; Navarro Grijalva M; Diaz Curiel M; Kanis JA Arch Osteoporos; 2019 Aug; 14(1):93. PubMed ID: 31440846 [TBL] [Abstract][Full Text] [Related]
15. A surrogate FRAX model for Pakistan. Naureen G; Johansson H; Iqbal R; Jafri L; Khan AH; Umer M; Liu E; Vandenput L; Lorentzon M; Harvey NC; McCloskey EV; Kanis JA Arch Osteoporos; 2021 Feb; 16(1):34. PubMed ID: 33595723 [TBL] [Abstract][Full Text] [Related]
16. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry. Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449 [TBL] [Abstract][Full Text] [Related]
17. A surrogate FRAX model for the Kyrgyz Republic. Lesnyak O; Zakroyeva A; Lobanchenko O; Johansson H; Liu E; Lorentzon M; Harvey NC; McCloskey E; Kanis JA Arch Osteoporos; 2020 May; 15(1):68. PubMed ID: 32377964 [TBL] [Abstract][Full Text] [Related]
18. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men. Yu R; Leung J; Woo J J Am Med Dir Assoc; 2014 Dec; 15(12):918-23. PubMed ID: 25262197 [TBL] [Abstract][Full Text] [Related]
19. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women. Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269 [TBL] [Abstract][Full Text] [Related]
20. Updated fracture incidence rates for the Italian version of FRAX®. Piscitelli P; Chitano G; Johannson H; Brandi ML; Kanis JA; Black DM Osteoporos Int; 2013 Mar; 24(3):859-66. PubMed ID: 22638710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]